Contraception
RSSArticles
Trends in Contraceptive Use Among Abortion Patients
In this cross-sectional study of 88,550 patients presenting for abortion services in England and Wales in 2018 and 2023, the use of effective methods of contraception decreased over time (hormonal methods: 18.8% vs. 11.3%, P < 0.001; long-acting reversible contraceptives: 3% vs. 0.6%, P < 0.001), while fertility awareness-based methods increased from 0.4% to 2.5% (P < 0.001).
Study Shows Increased Interest in New Male Contraceptive Gel
People are interested in a reversible and effective male contraceptive at a time when researchers are closer than ever to making this a reality, studies show.
Preterm Birth Predicts Lower Rate of Desired Permanent Contraception
A new study finds that patients who had preterm delivery were less likely to receive their desired permanent contraception when compared with patients who had at-term delivery.
Cervical Cancer Screening Is Important for All Women — Not Just Unvaccinated
Women who received the human papillomavirus (HPV) vaccine at the youngest age group of 9 to 12 years were less likely to participate in cervical cancer screening (a Pap test) than were those who received the vaccine during their teens and young adulthood, a new study finds.
Study Suggests Ways to Improve HPV Vaccination Rates
The most common sexually transmitted infection, human papillomavirus (HPV), also leads to a range of cancers in 10% of people infected with the virus. The most effective preventive measure is the HPV vaccine.
When Researching Youth Contraception, Include Young Voices in Study Design
Asking young people to contribute to research for improving contraceptive access can be a good strategy to improve contraception education and engagement that targets teenagers and young adults.
Who Is Most Likely to Seek Contraception from Publicly Supported Providers?
People with private health insurance typically obtain their contraceptive methods from private doctors’ offices, in-store clinics, or pharmacies, while just about everyone else relies on publicly funded health centers and family practice clinics for contraceptive care, a new study says.
How Common Are Hormonal Side Effects with the 52-mg Levonorgestrel IUD?
In this secondary analysis of the ACCESS IUS trial, participants who used combined hormonal contraceptives compared to nonhormonal contraceptives prior to enrolling were more likely to complain of acne in the first six months (13% vs. 8.5%, P = 0.006) and 12 months (15.7% vs. 10.6%, P = 0.005) of levonorgestrel intrauterine device use. Overall, the rate of discontinuation in the first six months because of adverse events was 5.5%, with no difference between the two groups.
Self-Testing for STIs Can Help Improve Access and Reduce Outbreaks
The increasing cases of syphilis, congenital syphilis, and some other sexually transmitted infections (STIs) in the post-pandemic era suggest clinicians and public health departments need additional strategies and tools to combat the problem.
Vaccine Hesitancy Could Dampen Enthusiasm for Vaccines to Combat STIs
While the sexually transmitted infection (STI) prevention world’s research pipeline contains new vaccines to fight major STIs — a potentially exciting development — there also is concern about growing vaccine hesitancy and misinformation in the United States.